Rockland Trust’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,685	Closed	-$330K	–	252
2018 Q3	$330K	Hold	2,685	–	–	0.04%	173
2018 Q2	$264K	Buy	+2,685	New	+$264K	0.03%	177